Sleep apnea is usually framed as a nuisance condition. Someone snores loudly, wakes up unrefreshed, feels tired during the day. Their partner sleeps in another room. It gets treated as a quality-of-life issue rather than a medical priority, and an enormous number of cases go undiagnosed entirely.
The research over the past decade suggests that framing understates the problem considerably. Obstructive sleep apnea is now recognized as a significant risk factor for cognitive decline and dementia, and the mechanisms connecting them are increasingly well understood.
What Obstructive Sleep Apnea Actually Does
Obstructive sleep apnea occurs when the airway repeatedly collapses during sleep, blocking airflow. Each episode causes oxygen levels to drop and triggers a brief arousal as the brain rouses the body enough to reopen the airway. The person typically has no memory of these arousals, but they can happen dozens or even hundreds of times per night.
Two things result. First, the person never reaches or sustains the deep, restorative stages of sleep, because they are constantly being pulled back toward wakefulness. Second, the brain experiences repeated cycles of oxygen deprivation, a condition called intermittent hypoxia.
Both matter for brain health, and both appear to contribute to the dementia association.
The Evidence
A 2025 meta-analysis published in GeroScience by Ungvari and colleagues examined the relationship between sleep disorders and dementia risk across 39 prospective cohort studies. The analysis found a significant association between obstructive sleep apnea and all-cause dementia, with a pooled hazard ratio of 1.33. For Alzheimer’s disease specifically, the association was stronger, with a hazard ratio of 1.45. Insomnia showed a comparable association with all-cause dementia at 1.36. The association between sleep apnea and vascular dementia did not reach statistical significance in this analysis.
A 2025 study published in Thorax by Wang and colleagues examined future dementia risk in people with obstructive sleep apnea syndrome managed in UK general practice. The authors concluded that further investigation is needed into the clinical benefits of screening for cognitive impairment in people with sleep apnea and into the effect of CPAP on cognitive decline and dementia risk.
Longitudinal cohort data has supported the association as well. The Sleep Heart Health Study, which followed more than 5,000 adults, found that those with severe sleep apnea had measurably worse executive function and processing speed at five-year follow-up.
A 2026 review examining the global burden of obstructive sleep apnea and cognitive decline noted that sleep apnea affects roughly 936 million adults worldwide and remains substantially underdiagnosed, particularly in lower and middle income countries.
Why It Affects the Brain
Several mechanisms have been identified, and they likely operate together.
Intermittent hypoxia. Repeated drops in blood oxygen cause oxidative stress and inflammation. The hippocampus, which is central to memory formation and is among the first regions damaged in Alzheimer’s disease, appears particularly sensitive to oxygen deprivation.
Disrupted slow-wave sleep. Deep, slow-wave sleep is when memory consolidation occurs and when the brain performs metabolic housekeeping. Sleep apnea fragments sleep architecture so severely that people may spend very little time in these restorative stages despite being in bed for eight hours.
Impaired glymphatic clearance. The glymphatic system is the brain’s waste clearance network, and it operates primarily during deep sleep. Amyloid-beta, the protein that accumulates as plaques in Alzheimer’s disease, is one of the waste products cleared during this process. When deep sleep is chronically disrupted, clearance is impaired and amyloid accumulates faster. This is one of the more compelling mechanistic links and connects sleep apnea directly to Alzheimer’s pathology.
Vascular effects. Sleep apnea is strongly associated with hypertension, stroke, and cardiovascular disease, all of which independently contribute to dementia risk through cerebrovascular damage.
Neuroinflammation. The combination of hypoxia and sleep fragmentation produces a sustained inflammatory response in the brain.
The Directionality Problem
It is worth being honest about a real limitation in this research.
The 2026 global burden review noted directly that while the mechanisms linking sleep apnea to cognitive decline are plausible, the directionality of these associations requires confirmation from longitudinal studies. A 2021 review published in Brain Sciences examining vulnerability and protective factors similarly noted that despite numerous epidemiological studies, there is still no full consensus on whether sleep apnea increases dementia risk, and that heterogeneity across studies may reflect individual characteristics that modify the relationship, including age, sex, menopause status, obesity, diabetes, hypertension, and APOE genotype.
The complication is that neurodegeneration can itself affect the brain regions controlling breathing during sleep, meaning sleep apnea could in some cases be an early consequence of dementia rather than a cause. Most researchers believe the relationship runs in both directions, but establishing the causal contribution of sleep apnea specifically requires longer follow-up than most studies have had.
Does Treatment Help?
This is the question that matters practically, and the answer is promising but not yet definitive.
A 2025 review published in Current Treatment Options in Neurology examining whether sleep apnea should be treated to prevent dementia found that short-term CPAP use led to modest improvements in cognitive performance, particularly in attention and processing speed. The benefits were variable, and adherence to CPAP was a crucial determinant of cognitive outcomes. The review concluded that there are potential cognitive benefits of CPAP in patients with mild cognitive impairment.
The 2026 global burden review reached a similar conclusion, noting that CPAP shows cognitive benefits when initiated early, while evidence for reversing established impairment remains limited.
Observational data suggests CPAP may slow cognitive decline in people with diagnosed sleep apnea, though large prospective trials designed specifically to answer this question are still ongoing. An NIH-funded study initiated in 2022 is examining the relationship between sleep apnea, cognitive decline, and dementia onset, and whether CPAP reduces those risks. The researchers noted that much of the existing debate stems from the limited number of studies with follow-up long enough to account for the extended preclinical phase during which sleep apnea may be affecting Alzheimer’s pathology.
The pattern here mirrors what was found with hearing loss and the ACHIEVE trial: a plausible mechanism, consistent observational associations, and randomized evidence that is suggestive but not yet conclusive.
Adherence Is the Practical Obstacle
CPAP only works if it is used, and adherence is notoriously poor. Many people abandon the machine within weeks because of mask discomfort, claustrophobia, dryness, or difficulty adjusting.
A study examining CPAP adherence in older adults with sleep apnea and amnestic mild cognitive impairment found that higher baseline cognitive function, better sleep quality, and stronger caregiver support were significant predictors of better adherence. The implication is that adherence becomes harder precisely as cognitive impairment progresses, which argues for addressing sleep apnea earlier rather than later.
For people who cannot tolerate CPAP, alternatives exist, including oral appliances, positional therapy, weight management, and in selected cases surgical options or hypoglossal nerve stimulation. A sleep physician can evaluate which alternatives are appropriate.
Who Should Be Evaluated
Sleep apnea is dramatically underdiagnosed, in part because the most obvious symptom, snoring, occurs while the person is asleep and is usually reported by a partner rather than noticed by the patient.
Signs worth evaluating include loud, chronic snoring, witnessed pauses in breathing during sleep, gasping or choking awakenings, waking unrefreshed despite adequate time in bed, significant daytime sleepiness, morning headaches, and difficulty concentrating. Risk factors include obesity, large neck circumference, male sex, older age, and postmenopausal status in women.
Diagnosis requires a sleep study, either in a lab or increasingly through home testing, which has made evaluation considerably more accessible than it once was.
For someone already experiencing cognitive complaints, screening for sleep apnea is a reasonable part of the workup, because it is both treatable and potentially contributing. Untreated sleep apnea can produce cognitive symptoms that look like early dementia, including attention problems, processing slowdown, and memory difficulty, which sometimes improve substantially with treatment.
Sleep apnea is one of several sleep-related factors that affect brain health. Our post on why sleep gets worse with dementia covers the broader relationship between sleep and neurodegeneration, including how the glymphatic system clears amyloid during deep sleep and why that process breaks down.
Have questions about memory care for a loved one?
We are happy to talk. Whether you are just starting to research your options or are further along in the process, reach out anytime.
463-444-9064 | Ben@HonorHavenSeniorLiving.com | Schedule a Tour
Sources
- Ungvari Z, Fekete M, Lehoczki A, et al. Sleep disorders increase the risk of dementia, Alzheimer’s disease, and cognitive decline: a meta-analysis. GeroScience. 2025;47(4).
- Wang J, Subramanian A, Cockburn N, Xiao J, Nirantharakumar K, Haroon S. Obstructive sleep apnoea syndrome and future risk of dementia among individuals managed in UK general practice. Thorax. 2025;80(3):167-174.
- Should We Treat Sleep Apnoea to Prevent Dementia? Current Treatment Options in Neurology. 2025;27.
- Legault J, Thompson C, Martineau-Dussault MÈ, et al. Obstructive Sleep Apnea and Cognitive Decline: A Review of Potential Vulnerability and Protective Factors. Brain Sciences. 2021;11(6):706.
- A Global Burden Perspective on Obstructive Sleep Apnea, Hearing Loss, and Early-Onset Cognitive Decline. 2026.
- Livingston G, et al. Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission. The Lancet. 2024;404(10452):572-628.